Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ACRS
AURA
Add up to 3 more stocks
ACRS
Aclaris Therapeutics, Inc.
-9.31%
$3.87-0.40Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$540.83M
52W Range
$1.74 - $6.60
AURA
Aura Biosciences, Inc.
-1.69%
$6.12-0.10Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$632.51M
52W Range
$4.73 - $9.54
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.34 | 2.01 |
| P/S Ratio | 65.80 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 73.3% | 0.0% |
| Operating Margin | -975.9% | 0.0% |
| Net Margin | -921.5% | 0.0% |
| ROE | -60.8% | -41.6% |
| ROA | -42.1% | -37.6% |
| ROIC | -57.0% | -42.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.46 | 16.82 |
| Quick Ratio | 3.46 | 16.82 |
| Debt/Equity | 0.00 | 0.05 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.